No abstract available
MeSH terms
-
Adalimumab
-
Adult
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents / adverse effects*
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / drug therapy
-
Demyelinating Diseases / chemically induced
-
Demyelinating Diseases / diagnosis
-
Etanercept
-
Female
-
Humans
-
Immunoglobulin G / adverse effects
-
Immunoglobulin G / therapeutic use
-
Immunoglobulin gamma-Chains / adverse effects
-
Immunoglobulin gamma-Chains / therapeutic use
-
Multiple Sclerosis / chemically induced*
-
Multiple Sclerosis / diagnosis
-
Optic Neuritis / chemically induced
-
Optic Neuritis / diagnosis
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Recombinant Fusion Proteins / adverse effects
-
Recombinant Fusion Proteins / therapeutic use
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Immunoglobulin G
-
Immunoglobulin gamma-Chains
-
Receptors, Tumor Necrosis Factor
-
Recombinant Fusion Proteins
-
Tumor Necrosis Factor-alpha
-
Ro 45-2081
-
Adalimumab
-
Etanercept